Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2019

May 2, 2019

3091_iss_2019-05-02_a31594ac-eac0-439d-a0ed-403a77e494c2.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Oncopeptides AB

Holder

Gladiator

Instrument

Instrument aktie SE0009414576
Before the transaction
Shares 2,486,056
Voting rights 2,486,056
Transaction
Reason for major shareholding notification Sell
Date 29/04/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 2,436,056
Directly held voting rights 2,436,056
Indirectly held voting rights 0
Percentage
Directly held shares 4.98 %
Directly held voting rights 4.98 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.98 % 2,436,056
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.98 % 2,436,056
Group total
holdings
Voting rights 2,436,056
Percentage of voting rights 4.98
Published 02/05/2019 15:36
Contact
Name Max Mitteregger
Phone 085450481 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25